New research on the structure of the human immunodeficiency virus (HIV) has revealed a promising novel drug target for treating HIV infection, which affects more than 1 million Americans and 40 million people worldwide. The ...
Apr 23, 2020
0
211
"Am I going to die?"
Apr 16, 2020
0
2
Stimulating immune cells with two cancer immunotherapies together can shrink the size of the viral "reservoir" in SIV-infected non-human primates treated with antiviral drugs, researchers have concluded. The reservoir includes ...
Mar 16, 2020
0
74
As my governor closes all the public schools and public libraries here in Seattle, I'm thinking about 1981—the year when newspapers in New York and Los Angeles reported that a strange new virus was killing healthy young ...
Mar 16, 2020
1
1
Despite significant progress against HIV/AIDS, the nation's capital is still battling an HIV epidemic with rates that are five times higher than the national average. A recent study by Milken Institute School of Public Health ...
Mar 9, 2020
0
97
Among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenofovir were more than 30% lower in those who were pregnant than in those who had recently given ...
Mar 9, 2020
0
1
New Zealand has avoided the high HIV rates seen among high-risk groups in other countries, a new study shows.
Feb 27, 2020
0
1
HIV and AIDS are still global health problems and sub-Saharan Africa remains the most affected region. Globally, around 770,000 people died from AIDS-related conditions in 2018, 160,000 of them in West and Central Africa.
Feb 12, 2020
0
1
The major obstacle to curing HIV is a vast reservoir of "latent, replication-competent proviruses," which have infiltrated the very cells that help orchestrate the immune response.
Antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects. ...
Jan 31, 2020
0
2
